Cargando…
Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas
BACKGROUND: Radiation treatment is commonly employed in the treatment of meningiomas. The aim of this study was to evaluate the effectiveness and safety of hypofractionated high-energy proton therapy as adjuvant or primary treatment for WHO grade I meningiomas. METHOD: A total of 170 patients who re...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686253/ https://www.ncbi.nlm.nih.gov/pubmed/29064038 http://dx.doi.org/10.1007/s00701-017-3352-4 |
_version_ | 1783278755346644992 |
---|---|
author | Vlachogiannis, Pavlos Gudjonsson, Olafur Montelius, Anders Grusell, Erik Isacsson, Ulf Nilsson, Kristina Blomquist, Erik |
author_facet | Vlachogiannis, Pavlos Gudjonsson, Olafur Montelius, Anders Grusell, Erik Isacsson, Ulf Nilsson, Kristina Blomquist, Erik |
author_sort | Vlachogiannis, Pavlos |
collection | PubMed |
description | BACKGROUND: Radiation treatment is commonly employed in the treatment of meningiomas. The aim of this study was to evaluate the effectiveness and safety of hypofractionated high-energy proton therapy as adjuvant or primary treatment for WHO grade I meningiomas. METHOD: A total of 170 patients who received irradiation with protons for grade I meningiomas between 1994 and 2007 were included in the study. The majority of the tumours were located at the skull base (n = 155). Eighty-four patients were treated post subtotal resection, 42 at tumour relapse and 44 with upfront radiotherapy after diagnosis based on the typical radiological image. Irradiation was given in a hypofractionated fashion (3–8 fractions, usually 5 or 6 Gy) with a mean dose of 21.9 Gy (range, 14–46 Gy). All patients were planned for follow-up with clinical controls and magnetic resonance imaging scans at 6 months and 1, 2, 3, 5, 7 and 10 years after treatment. The median follow-up time was 84 months. Age, gender, tumour location, Simpson resection grade and target volume were assessed as possible prognostic factors for post-irradiation tumour progression and radiation related complications. RESULTS: The actuarial 5- and 10-year progression-free survival rates were 93% and 85% respectively. Overall mortality rate was 13.5%, while disease-specific mortality was 1.7% (3/170 patients). Older patients and patients with tumours located in the middle cranial fossa had a lower risk for tumour progression. Radiation-related complications were seen in 16 patients (9.4%), with pituitary insufficiency being the most common. Tumour location in the anterior cranial fossa was the only factor that significantly increased the risk of complications. CONCLUSIONS: Hypofractionated proton-beam radiation therapy may be used particularly in the treatment of larger World Health Organisation grade I meningiomas not amenable to total surgical resection. Treatment is associated with high rates of long-term tumour growth control and acceptable risk for complications. |
format | Online Article Text |
id | pubmed-5686253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-56862532017-11-28 Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas Vlachogiannis, Pavlos Gudjonsson, Olafur Montelius, Anders Grusell, Erik Isacsson, Ulf Nilsson, Kristina Blomquist, Erik Acta Neurochir (Wien) Clinical Article - Brain Tumors BACKGROUND: Radiation treatment is commonly employed in the treatment of meningiomas. The aim of this study was to evaluate the effectiveness and safety of hypofractionated high-energy proton therapy as adjuvant or primary treatment for WHO grade I meningiomas. METHOD: A total of 170 patients who received irradiation with protons for grade I meningiomas between 1994 and 2007 were included in the study. The majority of the tumours were located at the skull base (n = 155). Eighty-four patients were treated post subtotal resection, 42 at tumour relapse and 44 with upfront radiotherapy after diagnosis based on the typical radiological image. Irradiation was given in a hypofractionated fashion (3–8 fractions, usually 5 or 6 Gy) with a mean dose of 21.9 Gy (range, 14–46 Gy). All patients were planned for follow-up with clinical controls and magnetic resonance imaging scans at 6 months and 1, 2, 3, 5, 7 and 10 years after treatment. The median follow-up time was 84 months. Age, gender, tumour location, Simpson resection grade and target volume were assessed as possible prognostic factors for post-irradiation tumour progression and radiation related complications. RESULTS: The actuarial 5- and 10-year progression-free survival rates were 93% and 85% respectively. Overall mortality rate was 13.5%, while disease-specific mortality was 1.7% (3/170 patients). Older patients and patients with tumours located in the middle cranial fossa had a lower risk for tumour progression. Radiation-related complications were seen in 16 patients (9.4%), with pituitary insufficiency being the most common. Tumour location in the anterior cranial fossa was the only factor that significantly increased the risk of complications. CONCLUSIONS: Hypofractionated proton-beam radiation therapy may be used particularly in the treatment of larger World Health Organisation grade I meningiomas not amenable to total surgical resection. Treatment is associated with high rates of long-term tumour growth control and acceptable risk for complications. Springer Vienna 2017-10-24 2017 /pmc/articles/PMC5686253/ /pubmed/29064038 http://dx.doi.org/10.1007/s00701-017-3352-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Clinical Article - Brain Tumors Vlachogiannis, Pavlos Gudjonsson, Olafur Montelius, Anders Grusell, Erik Isacsson, Ulf Nilsson, Kristina Blomquist, Erik Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas |
title | Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas |
title_full | Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas |
title_fullStr | Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas |
title_full_unstemmed | Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas |
title_short | Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas |
title_sort | hypofractionated high-energy proton-beam irradiation is an alternative treatment for who grade i meningiomas |
topic | Clinical Article - Brain Tumors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686253/ https://www.ncbi.nlm.nih.gov/pubmed/29064038 http://dx.doi.org/10.1007/s00701-017-3352-4 |
work_keys_str_mv | AT vlachogiannispavlos hypofractionatedhighenergyprotonbeamirradiationisanalternativetreatmentforwhogradeimeningiomas AT gudjonssonolafur hypofractionatedhighenergyprotonbeamirradiationisanalternativetreatmentforwhogradeimeningiomas AT monteliusanders hypofractionatedhighenergyprotonbeamirradiationisanalternativetreatmentforwhogradeimeningiomas AT grusellerik hypofractionatedhighenergyprotonbeamirradiationisanalternativetreatmentforwhogradeimeningiomas AT isacssonulf hypofractionatedhighenergyprotonbeamirradiationisanalternativetreatmentforwhogradeimeningiomas AT nilssonkristina hypofractionatedhighenergyprotonbeamirradiationisanalternativetreatmentforwhogradeimeningiomas AT blomquisterik hypofractionatedhighenergyprotonbeamirradiationisanalternativetreatmentforwhogradeimeningiomas |